Fraser Wright, PhD
Scientific Co-Founder and Chief Scientific Advisor
Fraser Wright is the Scientific Co-Founder and Chief Scientific Advisor of Kriya Therapeutics. Dr. Wright is a Professor of Pediatrics in the Center for Definitive and Curative Medicine at Stanford University. Previously, he was the co-founder and Chief Technology Officer of Spark Therapeutics, where he helped oversee the product development and manufacturing of LUXTURNA® and other pipeline programs. Prior to co-founding Spark Therapeutics, Dr. Wright was the founding Scientific Director of the Clinical Vector Core Laboratory at the Children’s Hospital of Philadelphia. He was also previously the director of development and clinical manufacturing at Avigen.
Dr. Wright received his PhD in Biochemistry and Molecular Immunology and his undergraduate degree in Biochemistry and Physiology from the University of Toronto.